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Uma síntese total e eficiente da (+) e (-)-tripargina, alcalóide b-carbolínico isolado da pele 
da rã africana K. Senegalensis, foi realizada em 6 etapas e 38% de rendimento global, a partir 
da triptamina, tendo como base a construção do sistema b-carbolínico via reação de Bischler-
Napieralski e a redução enantiosseletiva do intermediário diidro-b-carbolínico via reação de 
transferência de hidrogênio assimétrica usando o protocolo de Noyori. 
A concise and efficient total synhesis of (+)- and (-)-trypargine (6 steps and 38% overall 
yield), a 1-substituted b-carboline guanidine alkaloid isolated from the skin of the African frog 
K. senegalensis, was developed based on the construction of the b-carboline moiety via Bischler-
Napieralski reaction and the enantioselective reduction of the dihydro-b-carboline intermediate 
via an asymmetric transfer hydrogenation reaction using Noyori´s protocol.
Keywords: trypargine, tetrahydro b-carboline alkaloid, Bischler-Napieralski reaction, Noyori 
asymmetric transfer hydrogenation
Introduction
The b-carboline skeleton is widely distributed among 
natural products including yohimbine (yohimbine and 
alloyohimbine), corynantheidine (corynantheidine), 
Rauwolfia (reserpine) and Vinca (vincamine) alkaloids.1
(-)-Trypargine (1) is a b-carboline alkaloid which has 
been isolated from the skin of the African racophorid frog, 
Kassina senegalensis, by Akizawa et al.2 in 1982 and more 
recently has also been isolated in nearly racemic form from 
the methanol extract of the ground ascidian Eudistoma sp.3
The absolute configuration of natural (-)-trypargine 
(1) was initially assigned via resolution of its racemate, 
prepared via the Pictet-Spengler reaction between tryptamine 
and 4-guanidino butyraldehyde ethyleneacetal, followed 
by optical rotatory dispersion and circular dichroism 
studies.4 Ishikawa and co-workers4,5 established its absolute 
configuration by total synthesis via the Pictet-Spengler 
reaction between (R)-N-benzyl tryptophan methyl ester and 
2-ketoglutaric acid, followed by X-ray diffraction analysis of 
the corresponding methyl ester of the major diastereoisomer. 
Synthetic (-)-(S)-1-(3´-guanidinopropyl)-1,2,3,4-tetrahydro-b-
carboline was shown to be identical to natural (-)-trypargine 
(1) thus establishing its absolute configuration.
The presence of a b-carboline and a guanidine moieties 
in the structure of (-)-trypargine (1) has led to preliminary 
evaluation of its biological profile. Neither a full account 
of the biological properties nor its biosynthetic origin have 
been reported although one may envision trypargine (1) 
to be formed from tryptophan and the 2-keto carboxylic 
acid derived from arginine. It has been reported to 
be toxic to mice (LD50 = 16.9 mg kg-1, intravenous 
administration) although complete details of this study are 
lacking.5,6 Ireland and co-workers3 have failed to observe 
significant cytotoxicity in fractions containing trypargine 
alkaloids against human colon tumor cells. Additionally, 
(-)-trypargine (1) has been reported to block voltage gated 
sodium channels in squid axon membrane.7 
Our interest to further explore the biological profile of 
trypargine and analogues led us to consider the available 
methodologies for chirality transfer in order to develop 
a short and asymmetric route to these compounds which 
would secure enough quantities to carry out biological 
assessment. Our approach to a catalytic and asymmetric 
synthesis of (+)-trypargine (1) relied on our previous results 
on the enantioselective total syntheses of arborescidines 
when we successfully employed the Bischler-Napieralski 
protocol to assembly the 3,4-dihydro-b-carboline moiety, 
followed by the Noyori catalytic asymmetric hydrogen 
transfer reaction to reduce the intermediate prochiral 
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imine.8 Recently, Drabowicz and co-workers9 disclosed the 
total synthesis of (+)-trypargine (1) via the latter approach 
which prompted us to disclose our results in this topic.
Results and Discussion
Our approach to (R)-trypargine (1) was based on the 
construction of the dihydro-b-carboline moiety via the 
Bischler-Napieralski reaction of tryptamine derivative 4 
(Scheme 1). Among the routes evaluated to secure the 
preparation of intermediate 4, two emerged as the most 
efficient: introduction of the 3-aminopropionyl group via 
Curtius rearrangement on 5-ketopentanoyl tryptamine (3, 
Scheme 1, step b) or via N-acylation of tryptamine (2) 
with N-allyloxycarbonyl-4-aminobutyric acid (6, Scheme 
1, step d).
The thermolysis of acyl azides to the corresponding 
isocyanates is known as the thermal Curtius rearrangement 
and the reaction mechanism probably involves the 
concerted migration of the alkyl or aryl substituent in the 
carbonyl group to the nitrogen atom of the azido group 
with concomitant loss of dinitrogen.10-12 The isocyanate 
intermediate can be isolated when the reaction is carried 
out in non-nucleophilic solvent or can be intercepted by 
water, amines or alcohols to give the corresponding, amines, 
ureas or carbamates.
Starting from commercially available tryptamine 
(2), reaction with glutaric anhydride in acetone at room 
temperature provided the corresponding amide 3 in 
quantitative yield (Scheme 2). The Curtius rearrangement 
was carried out by treating a solution of amide 3 in acetone 
with methyl chloroformate in order to give rise to the 
corresponding mixed anhydride at 0 oC which was then 
converted to the corresponding acyl azide 7 upon treatment 
with aqueous sodium azide at rt. Acyl azide 7 was heated 
in toluene for 2 h and the reaction was quenched by the 
addition of allylic alcohol to provide, after chromatography 
on silica gel, allyl carbamate 4 in 73% overall yield from 
tryptamine (2).
Alternatively, allyl carbamate 4 was prepared in 88% 
yield via acylation of tryptamine (2) with N-carboallyloxy-
4-aminocarboxylic acid 6 and catalytic amount of 
N-hydroxybenzotriazol (HOBt) and 1-ethyl-3-(3-
dimethylaminopropyl)carbodiimide (EDCI).13 Despite the 
slight increase in the overall yield of allyl carbamate 4, the 
use of expensive reagents in the method employing 4-amino 
butyric acid makes the Curtius rearrangement the method 
of choice for large scale preparation.
With the preparation of allyl carbamate 4 secured, 
the formation of dihydro-b-carboline 9 was succesfully 
carried out upon treating 4 with 3 equivalents of POCl3 in 
toluene/acetonitrile (7:3, v/v) under reflux, to give 9 in 76% 
yield after column chromatography. However, it proved 
to be more efficient to filter the crude reaction mixture 
through a pad of silica gel in order to remove most of the 
contaminants and proceed to the next step, the asymmetric 
transfer hydrogenation under the conditions described by 
Noyori and coworkers. Using the protocol, (R)-(+)-10 
was obtained in 75% overall yield from allyl carbamate 4 
(Scheme 3).
Scheme 1. a) acetone, 20 min., rt; b) i: methyl chloroformate, acetone, 0 oC, 45 min; ii: NaN3, H2O, 2h; iii: toluene, reflux, 2h; iv: allylic alcohol, reflux, 
3h, 73% (two steps); c) NaHCO3, H2O, THF, rt. 24h, 100%; d) 2, HOBt, EDCI, THF, rt, 16h, 88%.
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The Bischler-Napieralski reaction is a cyclodehydration 
which takes place when an acyl derivative of a 
b-arylethylamine is treated with a dehydrating agent.14,15 
Mechanistic studies carried out by Fodor and coworkers have 
shown that the formation of imidoyl chloride and nitrilium 
intermediates is promoted by several dehydrating agents such 
as POCl3, PCl5 and SOCl2.16,17 In our case, the formation of 
the imidoyl chloride or nitrilium salt from the indole amine 
would be followed by an aromatic electrophilic substitution 
to afford dihydro-b-carboline 9 (Scheme 4).
The asymmetric reduction of the prochiral imine 9 
was efficiently carried out using the asymmetric transfer 
hydrogenation as devised by Noyori and co-workers.18 The 
reaction is catalyzed by chiral N-sulfonated diamine-Ru(II)-h6
arene complexes and has become the method of choice for 
the enantioselective reduction of cyclic imines due to the 
high yield and enantiomeric excess usually attained and 
the simplicity of the experimental protocol.19,20 Despite the 
advantages of this methodology, relatively few examples 
of asymmetric synthesis of natural products containing the 
tetrahydro-b-carboline core have appeared since our first 
disclosure of the application of Noyori asymmetric transfer 
hydrogenation in the total synthesis of arborescidines A, 
B and C.8,9,21-23
The 16 electron catalytic active species II was 
generated upon treatment of pre-catalyst RuCl(S,S)-
H2NCHPhCHPhNTs)(h-p-cymene) (I) in DMF at 80 oC 
in the presence of Et3N.24,25 Then, a solution of prochiral 
imine 9 in DMF was added, followed by a 5:2 formic 
acid-triethylamine azeotropic mixture and the reaction 
mixture was kept at room temperature for 8 h. Under 
these conditions tetrahydro-b-carboline 10 was isolated in 
75% overall yield from allyl carbamate 4. However, when 
longer reaction time was employed the hydrogenation of 
the allyloxy group present in 10 was also observed. 
The proposed mechanism involves the six-membered 
arrangement  IV which displays an hydrogen bond between 
the N-H in the chiral ligand and the nitrogen in the imine 
and hydride transfer from the ruthenium hydride species to 
the imine via an out-of-plane interaction between Ru-H and 
the C=N bonds. According to the working model proposed 
by Noyori and co-workers,18,19 the use of (S,S)-DPEN as 
the chiral ligand would direct the asymmetric transfer 
hydrogenation to take place at the Si face of prochiral imine 
9 leading to (R)-10 as the major enantiomer as depicted in 
Scheme 5.
Considering that the sense of chirality in the Noyori 
reduction would be validated by comparing the specific 
Scheme 3. a) POCl3, toluene/acetonitrile, reflux, 5h; b) (S,S)-TsDPEN-RuII, HCO2H-Et3N (5:2), DMF, rt, 8 h, 75% (two steps); c) Pd-C, Et3SiH, MeOH, 
90%; d)12, DIPEA, DMF, rt, 24 h, then, HCl/MeOH, 77%.
Scheme 2.
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optical rotation of synthetic trypargine (1) with that 
described for trypargine isolated from natural sources, we 
focused on the determination of the enantiomeric ratio of 
tetrahydro-b-carboline 11 which was shown to be 98:2 
after 19F-NMR spectroscopic analyses of the Mosher amide 
prepared from (R)-(-)-a-methoxy-a-(trifluoromethyl)
phenyl acetic acid (MTPA).
Our choice for the allyloxycarbonyl group in our 
synthetic scheme evolved after screening several different 
protecting groups (carbomethoxy, terc-butoxycarbonyl, 
benzyloxycarbonyl, 9-fluorenylmethoxycarbonyl and 
trifluorocarbonyl groups) as it proved to be compatible 
with the acidic conditions during the Bischler-Napieralski 
reaction using POCl3, the Noyori protocol for the transfer 
hydrogenation reaction and eventually it was easily removed 
under very mild conditions. In fact, by employing the 
conditions described by Mandal and McMurry, amine (R)-11 
was isolated in 90% yield after 30 min at rt in the presence 
of Et3SiH and catalytic amount of Pd/C in ethanol.26
The final step toward (R)-trypargine (1) was the 
introduction of the guanidine moiety which was 
carried out with the method described by Bernatowicz 
and co-workers4,9 which makes use of 1H-pyrazol-
1-carboxyamidine hydrochloride (12) in DMF and 
diisopropylethylamine. After column chromatography on 
basic alumina and treatment with methanolic HCl, (R)-
trypargine hydrochloride (1•HCl) was isolated in 77% yield. 
Its physical (melting point and specific optical rotation) and 
spectroscopic data (1H- and 13C-NMR data) nicely matched 
those described in the literature. 
Natural (S)-(-)-trypargine (1) was also prepared in 6 
steps and 38% overall yield from tryptamine according to 
the same reaction sequence. 
The approach described herein is robust enough to 
provide trypargine and its derivatives in both enantiomeric 
forms in few steps, good overall yield and very high 
enantiomeric ratios from tryptamine and analogues and 
should be of value for the determination of the absolute 
configuration of others dihydro-b-carbolines such as the 
novel toxin isolated from the venom of the Parawixia 
bistriata spider endemic in the brazilian cerrado27 and 
pharmacological screening of  related compounds.
Experimental
Commercially available reagents and solvents were 
previously purified. THF was distilled from calcium 
hydride and redistilled from sodium/benzophenone 
immediately prior to use. Dichloromethane, acetonitrile 
and triethylamine were distilled from calcium hydride 
immediately prior to use. Dimethylformamide (DMF) was 
distilled from calcium hydride under reduced pressure and 
Scheme 4.
Scheme 5.
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temperature lower than 70 oC. Methanol was distilled from 
magnesium containing catalytic amount of iodine. POCl3 
as distilled immediately prior to use. 
The reactions were monitored with TLC plates (aluminum 
foils covered with silica gel) and exposed to UV radiation, 
followed by treatment with fosfomolibdic acid (25% 
ethanolic solution) or aq. KMnO4 and heating on a hot plate. 
Chromatographic separations were carried out in silica gel 
(70-230 or 230-400 Mesh) or basic alumina (5-200 m).
Specific optical rotations were measured at 25 oC at 
589 nm (sodium D line) and IR spectra were measured 
as film in NaCl cells and frequencies are reported as cm-1. 
Melting points are not corrected.
1H- and 13C-NMR spectra were obtained in CDCl3 or 
CD3OD solutions at 250 and 62.5 MHz, respectively, or at 
300 and 75 MHz, respectively. Chemical shifts (d) were 
expressed in ppm and coupling constants in Hz. Multiplicity 
is reported as singlet (s), doublet (d), double dublets (dd), 
triplet (t), double triplet (dt), quartet (q), quintuplet (quint), 
multiplet (m) and broad singlet (br s).
5-{[2-(1H-Indol-3-yl)ethyl]amino}-5-oxopentanoic acid (3)
To a solution of glutaric anhydride (0.10 g, 0.88 mmol) 
in acetone (3 mL), was added tryptamine (0.15 g, 0.93 
mmol) dissolved in acetone (0.5 mL). The reaction mixture 
was stirred 20 min at rt. The solvent was evaporated under 
reduced pressure and the crude reaction mixture was purified 
through a pad of silica gel and ethyl acetate as eluent to 
provide carboxylic acid 3 pure enough to be used in the next 
step. mp 138-139 oC. IR (KBr) ν
max
/cm-1: 3400-2800, 1709, 
1645, 1543, 1225, 737. 1H-NMR (300 MHz, CD3OD) d 1.28 
(br s, 1H); 1.83-1.89 (m, 2H); 2.20 (t, J 6.5 Hz, 2H), 2.28 (t, 
J 6.5 Hz, 2H); 2.93 (t, J 7.2 Hz, 2H); 3.47 (t, J 7.5 Hz, 2H); 
6.96-7.10 (m, 3H); 7.32 (d, J 7.5 Hz, 1H), 7.54 (d, J 7.5 Hz, 
1H).13C-NMR (75 MHz, CD3OD) d 22.4 (CH2); 26.4 (CH2); 
34.2 (CH2); 36.3 (CH2); 41.5 (CH2); 112.4 (CH); 113.4 (C0); 
119.4 (CH); 119.7 (CH); 122.4 (CH); 123.5 (CH); 128.9 
(C0); 138.3 (C0); 175.5 (C0); 177.0 (C0). 
Allyl (4-{2-[1H-indol-3-yl)ethyl]amino)-4-oxobutyl)
carbamate (4)
To a solution of 3 (0.27 g, 1.0 mmol) and triethylamine 
(0.60 mL) in acetone (5 mL) at 0 oC was added dropwise 
methyl chloroformate (0.35 mL, 4.5 mmol). The reaction 
was stirred 45 min at rt and then a solution of sodium azide 
(0.28 g, 4.3 mmol) in water (1 mL) was added. The reaction 
mixture was stirred 2 h at rt and then concentrated under 
reduced pressure (Caution! Do not concentrate to dryness 
to the risk of explosion.). The crude mixture was diluted in 
CH2Cl2 (30 mL) and washed with brine (15 mL). The organic 
phase was dried with anhydrous magnesium sulfate and the 
solvent was removed under reduced pressure (Caution! Do 
not concentrate to dryness due to the risk of explosion). The 
residue was dissolved in toluene (20 mL) and the solution 
was refluxed 2 h under nitrogen atmosphere when allylic 
alcohol (0.38 mL, 5.6 mmol) was added and the reaction 
mixture was heated under reflux for 3 h. The reaction mixture 
was purified by column chromatography on silica gel and 
ethyl acetate-hexanes (1:1, v/v) as eluent to yield carbamate 
4 a pale brown solid in 73% yield (0.24 g, 0.70 mmol). mp 
84-86 oC. IR (KBr) ν
max
/cm-1: 3305, 1701, 1643, 1535, 1257. 
1H-NMR (250 MHz, CD3OD) d 1.78 (quint., J 7.0 Hz, 2H); 
2.15 (t, J 7.0 Hz, 2H); 2.90 (t, J 7.0 Hz, 2H); 3.15 (q, J 6.4 
Hz, 2H); 3.54 (q, J 6.4 Hz, 2H); 4.53 (d, J 5.5 Hz, 2H); 5.12-
5.32 (m, 3H); 5.82-5.98 (m, 1H); 6.05 (sl, 1H); 7.00-7.23 
(m, 3H); 7.32 (d, J 7.5 Hz, 1H), 7.64 (d, J 7.5 Hz, 1H); 8.50 
(br s, 1H). 13C-NMR (62.5 MHz, CD3OD) d 20.8 (CH2); 
21.5 (CH2); 29.2 (CH2); 35.5 (CH2); 36.1 (CH2); 61.0 (CH2); 
106.9 (CH); 108.3 (CH); 112.7 (C0); 114.2 (CH); 117.8 (CH); 
117.4 (=CH2); 117.9 (CH); 123.0 (C0); 128.8 (CH); 132.1 
(C0); 152.2 (C0); 168.3 (C0). HRMS (ESI+) Found 330.1887 
[M+H]+; calc. for C18H24N3O3+: 330.1812 (+20.1 ppm error).
4-{[(Allyloxy)carbonyl]amino}butanoic acid (6)
To a suspension of 4-aminobutyric acid (0.46 g, 4.5 mmol) 
in THF (10 mL) containing sat. aq. NaHCO3 (10 mL) 
at 0 oC, was added dropwise allyl chloroformate (0.5 mL, 
4.7 mmol). The reaction mixture was stirred 24 h at rt 
when conc. HCl was added dropwise to adjust to pH 2. The 
reaction mixture was extracted with CH2Cl2 (3 × 10 mL) and 
the organic phase was dried under anhydrous magnesium 
sulfate. The carbamate 6 was obtained in quantitative yield 
as viscous oil which was used in the next step without 
further purification. IR (KBr) ν
max
/cm-1: 3332, 2947, 1709, 
1538, 1255. 1H-NMR (250 MHz, CDCl3) d 1.85 (quint, 
J 7.0 Hz, 2H); 2.38 (t, J 7.2 Hz, 2H); 3.19-3.30 (m, 2H); 
4.53 (d, J 5.2 Hz, 2H); 5.08 (br s, 1H); 5.23 (d, J 10.4 Hz, 
1H); 5.27 (d, J 17.2 Hz, 1H); 5.89 (m, 1H); 7.55 (br s, 1H). 
13C-NMR (62.5 MHz, CDCl3) d 24.9 (CH2); 31.1 (CH2); 
40.2 (CH2); 65.6 (CH2); 117.7 (=CH2); 132.8 (CH); 156.5 
(C0); 178.0 (C0). HRMS (ESI+) Found 210.0773 [M+Na]+; 
calc. for C8H13NO4Na+: 210.0742 (+14.8 ppm error).
Allyl (4-{2-[1H-indol-3-yl)ethyl]amino)-4-oxobutyl)
carbamate (4)
To a solution of 6 (0.80 g, 4.3 mmol), HOBt (0.23 g, 
1.7 mmol) and EDCI (0.90 g, 4.7 mmol) in THF (15 mL) 
was added dropwise a solution of tryptamine (0.80 g, 
Pili and Rodrigues Jr. 1439Vol. 20, No. 8, 2009
5.0 mmol) in THF (10 mL). The reaction mixture was 
stirred 16 h at rt, quenched with brine (25 mL) and extracted 
with ethyl acetate (3 × 25 mL). The organic phase was dried 
over magnesium sulfate and evaporated under reduced 
pressure. After purification over a pad of silica gel with 
ethyl acetate as eluent, carbamate 4 was obtained in 88% 
yield (1.25 g, 3.78 mmol).
Allyl [3-(4,9-dihydro-3H-carbolin-1-yl)propyl]carbamate (9)
A solution of 4 (1.18 g, 3.56 mmol) in a mixture 
(7:3 v/v) of toluene/acetonitrile (30 mL) was added 
POCl3 (1 mL, 10 mmol) dropwise and the reaction 
mixture was refluxed for 5 h. The reaction mixture 
was cooled to rt and concentrated under vacuum. 
The crude mixture was dissolved in CH2Cl2 (40 mL) 
and washed with aq. 10% NH4OH (25 mL) and brine 
(2 × 25 mL), successively. The organic phase was dried 
with anhydrous magnesium sulfate and concentrated 
under reduced pressure. After purification over a pad 
of silica gel with ethyl acetate/methanol (10%, v/v) as 
eluent, carbamate 9 was obtained in quantitative yield 
(1.11 g, 3.56 mmol). 1H-NMR (250 MHz, CDCl3) d 1.98 
(quint, J 7.0 Hz, 2H); 2.74 (t, J 7.4 Hz, 2H); 2.85 (t, J 
8.6 Hz, 2H); 3.26 (q, J 6.4 Hz, 2H); 3.84 (t, J 8.6 Hz, 
2H); 4.53 (d, J 5.5 Hz, 2H); 5.16 (dd, J 1.4 and10.4 Hz, 
1H); 5.25 (dd, J 1.4 and 17.2 Hz, 1H); 5.57 (br, 1H); 
5.78-5.93 (m, 1H); 7.10-7.16 (m, 1H); 7.23-7.29 (m, 1H); 
7.40 (d, J 8.2 Hz, 1H); 7.57 (d, J 8.2 Hz, 1H). 13C-NMR 
(62.5 MHz, CDCl3) d 19.3 (CH2); 27.0 (CH2); 32.3 (CH2); 
40.7 (CH2); 47.8 (CH2); 65.6 (CH2); 112.2 (CH); 117.0 
(C0); 117.5 (=CH2); 119.9 (CH); 120.1 (CH); 124.5 (CH); 
125.3 (C0); 128.5 (C0); 132.7 (CH); 137.0 (C0); 156.9 
(C0); 161.3 (C0). HRMS (ESI+) Found 312.1722 [M+H]+; 
calc. for C18H22N3O2+: 312.1707 (+3.2 ppm error).
Allyl {3-[(1R)-2,3,4,9-tetrahydro-1H-b-carbolin-1-yl]
propyl}carbamate (10)
To a previously dried round-bottomed flask was added 
RuCl2(n-p-cymene) (5.4 mg, 8.8 µmol), (S,S)-TsDPEN 
(6.4 mg, 17.5 µmol), triethylamine (1.3 µL, 17.6 µmol) and 
dry DMF (2.0 mL) was heated 1 h at 80 oC. The mixture 
was cooled to rt and a solution of 9 (0.59 g, 1.9 mmol) 
in DMF (2 mL) was added followed by the addition of 
an azeotropic mixture of formic acid and triethylamine 
(1.0 mL, 5:2 v/v). The reaction mixture was kept 8 h at rt 
and then DMF was distilled under reduced pressure and 
the crude product was purified by column chromatography 
on silica gel (20% CHCl3/MeOH, v/v) to afford (0.45 g, 
1.42 mmol) in 75% yield as a viscous yellow oil. [a]D20 +27.0 
(c 1.0, MeOH). 1H-NMR (250 MHz, CD3OD) d1.14-1.34 
(m, 2H); 1.69-2.01 (m, 3H); 2.13-2.23 (m, 1H); 2.85-3.02 
(m, 2H); 3.20-3.25 (m, 2H); 4.51-4.53 (m, 2H); 5,16 (dd, J 
1.4 and 10.4 Hz, 1H); 5.28 (dd, J 1.4 and 17.2 Hz, 1H); 5.92 
(m, 1H); 7.00-7.14 (m, 2H); 7.34 (d, J 8.0 Hz, 1H); 7.44 
(d, J 8.0 Hz, 1H). 13C-NMR (62.5 MHz, CD3OD) d 20.5 
(CH2); 27.0 (CH2); 31.2 (CH2); 41.4 (CH2); 43.2 (CH2); 54.4 
(CH); 66.5 (CH2); 107.0 (C0); 112.4 (CH); 117.6 (=CH2); 
119.0 (CH); 120.4 (CH); 123.2 (CH); 127.8 (C0); 131.9 
(CH); 134.6 (C0); 138.2 (C0); 159.0 (C0). HRMS (ESI+) 
Found 314.1835 [M+H]+; calc. for C18H24N3O2+: 314.1869 
(-10.8 ppm error).
Allyl {3-[(1S)-2,3,4,9-tetrahydro-1H-b-carbolin-1-yl]
propyl}carbamate (10)
The reaction was carried out as described above for (R)-
10, except that the catalyst was prepared using (S)-TsDPEN 
instead of (R)-TsDPEN. [a]D20 –28.0 (c 1.0, MeOH).
{3-[(1R)-2,3,4,9-tetrahydro-1H-b-carbolin-1-yl)propyl}
amine (11)
To a previously dried round-bottomed flask containing 
(R)-10 (0.30 g, 0.95 mmol), 5% Pd/C (0.03 g) and methanol 
(15 mL) at rt was added dropwise triethylsilane (0.75 mL, 
4.7 mmol). The reaction mixture was stirred 30 min at rt 
and filtered to remove the catalyst. The solvent was removed 
under reduced pressure and the crude product was purified on 
basic alumina (ethyl acetate and 20% ethyl acetate/methanol 
as eluents) to afford pale brown oil (0.20 g, 0.85 mmol) 
in 90% yield. [a]D20 +75.0 (c 1.0, MeOH), IR (KBr) 
ν
max
/cm-1: 3453 and 3245. 1H-NMR (250 MHz, CD3OD) 
d 1.60-1.76 (m, 2H); 1.96-2.07 (m, 2H); 2.65-2.78 (m, 4H); 
2.90-2.98 (m, 2H); 4.01-4.05 (m, 1H); 6.95-7.10 (m, 2H); 
7.29-7.41 (m, 2H). 13C-NMR (62.5 MHz, CD3OD) d 22.4 
(CH2); 25.6 (CH2); 32.9 (CH2); 40.9 (CH2); 43.2 (CH2); 53.5 
(CH); 109.2 (C0); 112.7 (CH); 118.8 (CH); 120.0 (CH); 
122.5 (CH); 128.5 (C0); 135.0 (C0); 138.0 (C0).
{3-[(1S)-2,3,4,9-tetrahydro-1H-b-carbolin-1-yl)propyl}
amine (11)
The same procedure as described above was employed 
to afford (S)-11 in 87% yield [a]D20 –74.0 (c 1.0, MeOH).
(+)-(R)-Trypargine Hydrochloride (1a)
To a solution of (R)-11 (0.110 g, 0.5 mmol) in DMF 
(1 mL) was added pyrazole 12 (0.075 g, 0.5 mmol) and 
diisopropylethylamine (0.25 mL, 1.4 mmol). The reaction 
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mixture was stirred 24 h at rt when DMF was removed 
under reduced pressure. The crude product was purified 
by column chromatography on basic alumina (chloroform/
methanol 30%, v/v) to afford (+)-(R)-trypargine (0.104 g, 
0.38 mmol) in 77% yield as a yellow solid which was 
treated with methanolic HCl to obtain (+)-(R)-trypargine 
hydrochloride as a yellow solid. mp 213-214 oC; [a]D20+32 
(c 1.0, MeOH); {lit.9: 210-213 oC; [a]D23 +34.3 (c 1.0, 
MeOH)}. IR (KBr) ν
max
/cm-1: 3350, 2934, 1660. 1H-RMN 
(250 MHz, CD3OD) d 1.87-1.96 (m, 2H); 2.01-2.10 (m, 
1H); 2.30-2.40 (m, 1H); 2.85-3.15 (m, 2H); 3.28-3.50 (m, 
3H); 3.67-3.71 (m, 1H); 4.70-4.78 (m, 1H); 7.04 (t, J 7.2 
Hz, 1H); 7.14 (t, J 7.2 Hz, 1H); 7.38 (d, J 8.0 Hz, 1H); 
7.47 (d, J 8.0 Hz, 1H). 13C-NMR (62.5 MHz, CD3OD) 
d 19.4 (CH2); 25.8 (CH2); 30.5 (CH2); 42.0 (CH2); 43.0 
(CH2); 54.4 (CH); 107.4 (C0); 112.4 (CH); 119.1 (CH); 
120.6 (CH); 123.5 (CH); 127.3 (C0); 129.7 (C0); 138.3 (C0); 
158.6 (C0). HRMS (ESI+) Found 272.1884 [M+H]+; calc. 
for C15H22N5+: 272.1875 (+3.3 ppm error).
(-)-(S)-Trypargine Hydrochloride (1b)
The same procedure as above was employed starting 
from (S)-3-(2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indol-
1-yl)propan-1-amine (11b) to afford (-)-(S)-trypargine 
hydrochloride (1) in 78% yield, [a]D20 +34 (1.0, MeOH).
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Figure S1. 1H NMR for compound 3 (300 MHz, CD3OD).
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Figure S2. 13C NMR for compound 3 (75 MHz, CD3OD).
Figure S3. 1H NMR for compound 4 (250 MHz, CD3OD).
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Figure S5. 1H NMR for compound 6 (250 MHz, CDCl3).
Figure S4. 13C NMR for compound 4 (62,5 MHz, CD3OD).
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Figure S6. 13C NMR for compound 6 (62,5 MHz, CDCl3).
Figure S7. 1H NMR for compound 9 (250 MHz, CDCl3).
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Figure S8. 13C NMR for compound 9 (62,5 MHz, CDCl3).
Figure S9. 1H NMR for compound 10 (250 MHz, CD3OD).
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Figure S10. 13C NMR for compound 10 (62,5 MHz, CD3OD).
Figure S11. 1H NMR for compound 11 (250 MHz, CD3OD).
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Figure S13. 1H NMR for compound 1 (250 MHz, CD3OD).
Figure S12. 13C NMR for compound 11 (62,5 MHz, CD3OD).
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Figure S14. 13C NMR for compound 1 (62.5 MHz, CD3OD).
